OVEREXPRESSION OF KIF11 IS A POOR PROGNOSTIC FACTOR IN CLEAR CELL RENAL CELL CARCINOMA

被引:0
作者
Kowalewski, Adam Michal [1 ,2 ,5 ]
Jaworski, Damian [3 ]
Antosik, Paulina [1 ]
Smolinska, Marta [1 ]
Ligmanowska, Joanna [1 ]
Grzanka, Dariusz [1 ]
Szylberg, Lukasz [2 ,4 ]
机构
[1] Nicolaus Copernicus Univ Torun, Chair & Dept Clin Pathomorphol, Coll Med Bydgoszcz, Bydgoszcz, Poland
[2] Prof Franciszek Lukaszczyk Mem Hosp, Oncol Ctr, Dept Tumor Pathol & Pathomorphol, Bydgoszcz, Poland
[3] Nicolaus Copernicus Univ Torun, Dept Ophthalmol, Div Ophthalmol & Optometry, Coll Med Bydgoszcz, Bydgoszcz, Poland
[4] Nicolaus Copernicus Univ, Dept Perinatol Gynaecol & Gynaecol Oncol, Coll Med Bydgoszcz, Bydgoszcz, Poland
[5] Nicolaus Copernicus Univ Torun, Chair & Dept Clin Pathomorphol, Coll Med Bydgoszcz, Curie Sklodowskiej 9 St, PL-85094 Bydgoszcz, Poland
关键词
KIF11; ccRCC; kidney cancer; renal carcinoma; expression; prognosis; survival; OS; INHIBITOR VORINOSTAT; PHASE-I; CANCER; APOPTOSIS; EXPRESSION; MIGRATION;
D O I
10.5114/PJP.2022.118137
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Unresectable renal cell carcinoma continues to be a great challenge due to our limit ed understanding of its underlying pathophysiology. We explored the relation-ship between KIF11 protein expression and the clinical courses of clear cell renal cell carcinoma (ccRCC) using a tissue microarray.Material and methods: The tissue microarray contained specimens derived from 90 patients, cancer and matched adjacent non-cancerous tissue (2 cores per case), followed up for 7 years. Tumour samples were evaluated for KIF11 expression using the H-score, and their correlations with clinicopathological data and survival data were analysed.72.7% of ccRCC tissues presented KIF11 cytoplasmic expression with a median value of 20 (interquartile range 0-200). The nuclear staining was positive in 36.36% of ccRCC tissues. Among controls, nuclear KIF11 expression was ab-sent, but cytoplasmic expression was identified in all cases, with a median value of 230 (interquartile range 45-290). Cytoplasmic KIF11 expression in ccRCC tis-sues was lower than in the control tissues and was positively correlated with tu-mour grade and mortality (p < 0.05). KIF11 nuclear expression did not correlate with overall survival.Elevated expression of KIF11 predicts poor clinical outcome in ccRCC patients. Downregulation of KIF11 may provide a new therapeutic strategy for ccRCC.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 33 条
[11]   Targeting the cancer epigenome for therapy [J].
Jones, Peter A. ;
Issa, Jean-Pierre J. ;
Baylin, Stephen .
NATURE REVIEWS GENETICS, 2016, 17 (10) :630-641
[12]   Epigenetics in renal cell cancer: mechanisms and clinical applications [J].
Joosten, Sophie C. ;
Smits, Kim M. ;
Aarts, Maureen J. ;
Melotte, Veerle ;
Koch, Alexander ;
Tjan-Heijnen, Vivianne C. ;
van Engeland, Manon .
NATURE REVIEWS UROLOGY, 2018, 15 (07) :430-451
[13]   Targeting the Deterministic Evolutionary Trajectories of Clear Cell Renal Cell Carcinoma [J].
Kowalewski, Adam ;
Zdrenka, Marek ;
Grzanka, Dariusz ;
Szylberg, Lukasz .
CANCERS, 2020, 12 (11) :1-13
[14]   The prognostic role of Eg5 expression in laryngeal squamous cell carcinoma [J].
Lu, Meiping ;
Zhu, Huijun ;
Wang, Xudong ;
Zhang, Dawei ;
Xiong, Lin ;
Xu, Li ;
You, Yiwen .
PATHOLOGY, 2016, 48 (03) :214-218
[15]   Filanesib for the treatment of multiple myeloma [J].
Macarena Algarin, Esperanza ;
Hernandez-Garcia, Susana ;
Garayoa, Mercedes ;
Ocio, Enrique M. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (01) :5-14
[16]   Kinesin Family Member 11 Enhances the Self-Renewal Ability of Breast Cancer Cells by Participating in the Wnt/β-Catenin Pathway [J].
Pei, Yuan-yuan ;
Li, Gao-chi ;
Ran, Jian ;
Wan, Xin-hong ;
Wei, Feng-xiang ;
Wang, Lan .
JOURNAL OF BREAST CANCER, 2019, 22 (04) :522-532
[17]   Kinesin Family Member 11 mRNA Expression Predicts Prostate Cancer Aggressiveness [J].
Piao, Xuan-Mei ;
Byun, Young Joon ;
Jeong, Pildu ;
Ha, Yun-Sok ;
Yoo, Eun Sang ;
Yun, Seok Joong ;
Kim, Wun-Jae .
CLINICAL GENITOURINARY CANCER, 2017, 15 (04) :450-454
[18]   Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial [J].
Pili, Roberto ;
Liu, Glenn ;
Chintala, Sreenivasulu ;
Verheul, Hendrick ;
Rehman, Shabnam ;
Attwood, Kristopher ;
Lodge, Martin A. ;
Wahl, Richard ;
Martin, James I. ;
Miles, Kiersten Marie ;
Paesante, Silvia ;
Adelaiye, Remi ;
Godoy, Alejandro ;
King, Serina ;
Zwiebel, James ;
Carducci, Michael A. .
BRITISH JOURNAL OF CANCER, 2017, 116 (07) :874-883
[19]   Wnt signaling in triple-negative breast cancer [J].
Pohl, SO-G ;
Brook, N. ;
Agostino, M. ;
Arfuso, F. ;
Kumar, A. P. ;
Dharmarajan, A. .
ONCOGENESIS, 2017, 6 :e310-e310
[20]   Epidemiology, Aetiology, and Pathogenesis of Renal Cell Carcinoma [J].
Protzel, Chris ;
Maruschke, Matthias ;
Hakenberg, Oliver W. .
EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (03) :52-59